Geneos Wealth Management’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.9K | Hold |
195
| – | – | ﹤0.01% | 1900 |
|
|
2025
Q4 | $11.5K | Hold |
195
| – | – | ﹤0.01% | 1922 |
|
|
2025
Q3 | $10.8K | Sell |
195
-643
| -77% | -$33.4K | ﹤0.01% | 1941 |
|
|
2025
Q2 | $36.1K | Sell |
838
-606
| -42% | -$23.4K | ﹤0.01% | 1739 |
|
|
2025
Q1 | $57.2K | Buy |
1,444
+1,091
| +309% | +$48.3K | ﹤0.01% | 1846 |
|
|
2024
Q4 | $14.4K | Hold |
353
| – | – | ﹤0.01% | 1887 |
|
|
2024
Q3 | $13.8K | Buy |
353
+164
| +87% | +$6.53K | ﹤0.01% | 1707 |
|
|
2024
Q2 | $8.26K | Hold |
189
| – | – | ﹤0.01% | 1596 |
|
|
2024
Q1 | $9.02K | Hold |
189
| – | – | ﹤0.01% | 1566 |
|
|
2023
Q4 | $8.93K | Hold |
189
| – | – | ﹤0.01% | 1576 |
|
|
2023
Q3 | $9K | Sell |
189
-10
| -5% | -$546 | ﹤0.01% | 1604 |
|
|
2023
Q2 | $11.6K | Buy |
199
+95
| +91% | +$5.7K | ﹤0.01% | 1536 |
|
|
2023
Q1 | $7.44K | Sell |
104
-65
| -38% | -$5.16K | ﹤0.01% | 1625 |
|
|
2022
Q4 | $11.9K | Sell |
169
-51
| -23% | -$3.6K | ﹤0.01% | 1483 |
|
|
2022
Q3 | $13K | Sell |
220
-267
| -55% | -$17.9K | ﹤0.01% | 1449 |
|
|
2022
Q2 | $30K | Buy |
487
+239
| +96% | +$15.6K | ﹤0.01% | 1495 |
|
|
2022
Q1 | $15K | Hold |
248
| – | – | ﹤0.01% | 1917 |
|
|
2021
Q4 | $17K | Hold |
248
| – | – | ﹤0.01% | 1969 |
|
|
2021
Q3 | $18K | Sell |
248
-26
| -9% | -$2.05K | ﹤0.01% | 1975 |
|
|
2021
Q2 | $22K | Buy |
274
+143
| +109% | +$11.5K | ﹤0.01% | 1876 |
|
|
2021
Q1 | $10K | Hold |
131
| – | – | ﹤0.01% | 2386 |
|
|
2020
Q4 | $10K | Sell |
131
-286
| -69% | -$18.6K | ﹤0.01% | 2218 |
|
|
2020
Q3 | $20K | Hold |
417
| – | – | ﹤0.01% | 1658 |
|
|
2020
Q2 | $19K | Hold |
417
| – | – | ﹤0.01% | 1645 |
|
|
2020
Q1 | $13K | Hold |
417
| – | – | ﹤0.01% | 1697 |
|
|
2019
Q4 | $36K | Hold |
417
| – | – | ﹤0.01% | 1427 |
|
|
2019
Q3 | $35K | Hold |
417
| – | – | ﹤0.01% | 1350 |
|
|
2019
Q2 | $43K | Hold |
417
| – | – | ﹤0.01% | 1272 |
|
|
2019
Q1 | $44K | Hold |
417
| – | – | ﹤0.01% | 1208 |
|
|
2018
Q4 | $34K | Hold |
417
| – | – | ﹤0.01% | 1276 |
|
|
2018
Q3 | $42K | Hold |
417
| – | – | ﹤0.01% | 1253 |
|
|
2018
Q2 | $33K | Hold |
417
| – | – | ﹤0.01% | 1238 |
|
|
2018
Q1 | $30K | Sell |
417
-7
| -2% | -$524 | ﹤0.01% | 1223 |
|
|
2017
Q4 | $29K | Hold |
424
| – | – | ﹤0.01% | 1245 |
|
|
2017
Q3 | $26K | Sell |
424
-126
| -23% | -$7.46K | ﹤0.01% | 1229 |
|
|
2017
Q2 | $31K | Sell |
550
-4
| -0.7% | -$235 | ﹤0.01% | 1112 |
|
|
2017
Q1 | $33K | Buy |
554
+1
| +0.2% | +$57 | ﹤0.01% | 1049 |
|
|
2016
Q4 | $30K | Buy |
553
+3
| +0.5% | +$144 | ﹤0.01% | 1023 |
|
|
2016
Q3 | $25K | Buy |
550
+7
| +1% | +$296 | ﹤0.01% | 1051 |
|
|
2016
Q2 | $18K | Buy |
+543
| New | +$17K | ﹤0.01% | 1149 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Geneos Wealth Management's NGVT Position: Q1 2026 in Review
Geneos Wealth Management held its Ingevity (NGVT) position steady in Q1 2026 at 195 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1900.
Geneos Wealth Management first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $57.2K in Q1 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Geneos Wealth Management held 195 shares of Ingevity worth $13.9K as of Q1 2026.
- Geneos Wealth Management left its Ingevity share count unchanged in Q1 2026.
- Ingevity made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1900 holding.
- Geneos Wealth Management first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
- Geneos Wealth Management's Ingevity position peaked at $57.2K in Q1 2025.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.